top of page

Ovid's Jeremy Levin on advances in CNS, soticlestat, ROCK2, Washington and more

Jeremy Levin walks us through the science of Ovid's CNS-focused pipeline, gives his take on the health of the biotech, and why it is important to not let populism drag the sector down.




Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page